PELP1 and ERβ are co-localized in various cell types within CRC tumors, while ERβ expression correlates with improved outcomes, and PELP1 overexpression in epithelial cells is an independent favorable prognostic factor [104]. Here, ESR2 is linked to colorectal carcinoma.